Prelude Capital Management’s Rhythm Pharmaceuticals RYTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-10,706
Closed -$464K 1368
2024
Q1
$464K Sell
10,706
-6,700
-38% -$290K 0.02% 598
2023
Q4
$800K Buy
17,406
+1,000
+6% +$46K 0.05% 295
2023
Q3
$376K Buy
+16,406
New +$376K 0.02% 468
2019
Q3
Sell
-365
Closed -$8K 1521
2019
Q2
$8K Buy
+365
New +$8K ﹤0.01% 1051